Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host.
Sonnleitner ST, Prelog M, Sonnleitner S, Hinterbichler E, Halbfurter H, Kopecky DBC, Almanzar G, Koblmüller S, Sturmbauer C, Feist L, Horres R, Posch W, Walder G. Sonnleitner ST, et al. Among authors: posch w. Nat Commun. 2022 May 10;13(1):2560. doi: 10.1038/s41467-022-30163-4. Nat Commun. 2022. PMID: 35538074 Free PMC article.
An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value.
Sonnleitner ST, Dorighi J, Jansen B, Schönegger C, Gietl S, Koblmüller S, Sturmbauer C, Posch W, Walder G. Sonnleitner ST, et al. Among authors: posch w. Virol J. 2021 Apr 7;18(1):71. doi: 10.1186/s12985-021-01542-y. Virol J. 2021. PMID: 33827618 Free PMC article.
Correction to: An in vitro model for assessment of SARS‑CoV‑2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS‑CoV‑2 from oropharyngeal swabs correlates negatively with Cq value.
Sonnleitner ST, Dorighi J, Jansen B, Schönegger C, Gietl S, Koblmüller S, Sturmbauer C, Posch W, Walder G. Sonnleitner ST, et al. Among authors: posch w. Virol J. 2021 Apr 20;18(1):82. doi: 10.1186/s12985-021-01558-4. Virol J. 2021. PMID: 33879217 Free PMC article. No abstract available.
Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients.
Sonnleitner ST, Prelog M, Jansen B, Rodgarkia-Dara C, Gietl S, Schönegger CM, Koblmüller S, Sturmbauer C, Posch W, Almanzar G, Jury H, Loney T, Tichy A, Nowotny N, Walder G. Sonnleitner ST, et al. Among authors: posch w. Transbound Emerg Dis. 2022 May;69(3):1596-1605. doi: 10.1111/tbed.14130. Epub 2021 May 27. Transbound Emerg Dis. 2022. PMID: 33960696 Free PMC article.
The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro.
Sonnleitner ST, Sonnleitner S, Hinterbichler E, Halbfurter H, Kopecky DBC, Koblmüller S, Sturmbauer C, Posch W, Walder G. Sonnleitner ST, et al. Among authors: posch w. Virol Sin. 2022 Apr;37(2):198-207. doi: 10.1016/j.virs.2022.01.029. Epub 2022 Jan 29. Virol Sin. 2022. PMID: 35277373 Free PMC article.
Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods.
Bayerl F, Bejarano DA, Bertacchi G, Doffin AC, Gobbini E, Hubert M, Li L, Meiser P, Pedde AM, Posch W, Rupp L, Schlitzer A, Schmitz M, Schraml BU, Uderhardt S, Valladeau-Guilemond J, Wilflingseder D, Zaderer V, Böttcher JP. Bayerl F, et al. Among authors: posch w. Eur J Immunol. 2023 Nov;53(11):e2249923. doi: 10.1002/eji.202249923. Epub 2023 Jan 9. Eur J Immunol. 2023. PMID: 36623939
Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants.
Sonnleitner ST, Walder S, Knabl L, Poernbacher R, Tschurtschenthaler T, Hinterbichler E, Sonnleitner S, Muehlmann V, Posch W, Walder G. Sonnleitner ST, et al. Among authors: posch w. Front Immunol. 2023 May 15;14:1165769. doi: 10.3389/fimmu.2023.1165769. eCollection 2023. Front Immunol. 2023. PMID: 37256137 Free PMC article.
Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
Lafon E, Diem G, Witting C, Zaderer V, Bellmann-Weiler RM, Reindl M, Bauer A, Griesmacher A, Fux V, Hoermann G, Miller C, Zabernigg A, Wöll E, Wilflingseder D, Lass-Flörl C, Posch W. Lafon E, et al. Among authors: posch w. Front Immunol. 2021 Jun 14;12:684014. doi: 10.3389/fimmu.2021.684014. eCollection 2021. Front Immunol. 2021. PMID: 34194438 Free PMC article.
95 results